BIRC5 and breast cancer: In addition to MCF‐7 cells, we also noted that LKB1 (Figure S4) or AMPK (Figure S5) contributes to lovastatin‐induced survivin reduction in another subtype breast cancer cells, MDA‐MB‐231 cells.